Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Complicações Relacionadas à EXtubação - o Estudo EXTUBE (EXTUBE) (EXTUBE)

19 de outubro de 2026 atualizado por: University Health Network, Toronto

Complicações relacionadas à EXtubação - um estudo observacional internacional para compreender o impacto e as melhores práticas no centro cirúrgico e na unidade de terapia intensiva - o estudo EXTUBE

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

Visão geral do estudo

Status

Recrutamento

Condições

Descrição detalhada

Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.

Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.

There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.

EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study

The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.

Tipo de estudo

Observacional

Inscrição (Estimado)

3000

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

  • Nome: Shayan Wasim, MPH, BSc
  • Número de telefone: 4221 +1 416 340 4800
  • E-mail: shayan.wasim@uhn.ca

Locais de estudo

    • New South Wales
      • Sydney, New South Wales, Austrália, 2065
        • Concluído
        • Royal North Shore Hospital
    • Victoria
      • Melbourne, Victoria, Austrália, 3135
        • Concluído
        • Eastern Health - Maroondah Hospital
      • Melbourne, Victoria, Austrália, 3156
        • Concluído
        • Eastern Health - Angliss Hospital
      • Melbourne, Victoria, Austrália, 3076
        • Concluído
        • The Northern Hospital
      • Melbourne, Victoria, Austrália, 3128
        • Concluído
        • Eastern Health - Box Hill Hospital
      • Melbourne, Victoria, Austrália, 3084
        • Concluído
        • Austin Health - Austin Hospital
      • Melbourne, Victoria, Austrália, 3079
        • Concluído
        • Austin Health - Heidelberg Repatriation Hospital
    • British Columbia
      • Surrey, British Columbia, Canadá, V3V 1Z2
        • Concluído
        • Surrey Memorial Hospital
    • New Brunswick
      • Moncton, New Brunswick, Canadá, E1C 4B7
        • Concluído
        • The Moncton Hospital
    • Ontario
      • North York, Ontario, Canadá, M4N 3M5
        • Concluído
        • Sunnybrook Hospital
      • Saint Catharines, Ontario, Canadá, L2S 0A9
        • Concluído
        • Niagara Health - Marotta Family Hospital
      • Toronto, Ontario, Canadá, M5B 1W8
        • Concluído
        • St. Michael's Hospital
      • Toronto, Ontario, Canadá, M5G 1X5
        • Concluído
        • Mount Sinai Hospital
      • Toronto, Ontario, Canadá, M5G 2C4
        • Recrutamento
        • University Health Network - Toronto General Hospital
        • Contato:
        • Investigador principal:
          • Matteo Parotto, MD, PhD
        • Contato:
        • Subinvestigador:
          • Alicia Grassi, MD
      • Toronto, Ontario, Canadá, M5T 2S8
        • Concluído
        • University Health Network - Toronto Western Hospital
    • Quebec
      • Montreal, Quebec, Canadá, H2X 0C1
        • Concluído
        • Centre hospitalier de l'Université de Montréal (CHUM)
      • Singapore, Cingapura, 308433
        • Concluído
        • Tan Tock Seng Hospital
      • Piedecuesta, Colômbia
        • Concluído
        • Hospital Internacional de Colombia
    • Arizona
      • Tucson, Arizona, Estados Unidos, 85724-5114
        • Concluído
        • Banner University Medical Centre
    • Arkansas
      • Little Rock, Arkansas, Estados Unidos, 72205
        • Concluído
        • University of Arkansas for Medical Sciences
    • Florida
      • Gainesville, Florida, Estados Unidos, 32608
        • Concluído
        • University of Florida
    • Illinois
      • Chicago, Illinois, Estados Unidos, 60637
        • Concluído
        • The University of Chicago
    • Oregon
      • Portland, Oregon, Estados Unidos, 97239
        • Concluído
        • Oregon Health & Science University
    • Texas
      • Houston, Texas, Estados Unidos, 77030
        • Concluído
        • The University of Texas Health Science Center
      • Castlebar, Irlanda, F23 H529
        • Concluído
        • Mayo University Hospital
      • Cork, Irlanda, T12 DFK4
        • Concluído
        • Cork University Hospital
      • Dublin, Irlanda, D07 R2WY
        • Concluído
        • Mater Misericordiae University Hospital
      • Galway, Irlanda, H91 YR71
        • Concluído
        • Galway University Hospitals
      • Waterford, Irlanda, X91 ER8E
        • Ainda não está recrutando
        • University Hospital Waterford
        • Contato:
        • Contato:
        • Investigador principal:
          • Dulmi T Nawarathna, MBBS, MCAI, FCAI
        • Subinvestigador:
          • Sheeba Hakak, MBBS, FCARCSI, EDIC, HCM.
      • Kuwait City, Kuwait
        • Concluído
        • Amiri Hospital
      • Auckland, Nova Zelândia, 1023
        • Concluído
        • Auckland City Hospital
      • Invercargill, Nova Zelândia, 9812
        • Concluído
        • Southland Hospital
      • Rotorua, Nova Zelândia, 3010
        • Concluído
        • Rotorua Hospital
      • Bath, Reino Unido, BA1 3NG
        • Concluído
        • Royal United Hospitals Bath
      • Newcastle upon Tyne, Reino Unido, NE7 7DN
        • Concluído
        • Freeman Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra de Probabilidade

População do estudo

All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window (up to 4 weeks).

Descrição

Inclusion Criteria:

  • Adult patients (≥18 years old)
  • Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
  • Undergoing extubation during the specified enrollment window

Exclusion Criteria:

  • Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
  • Patients will be excluded if the extubation is performed for tracheostomy decannulation

For each patient who is not included, reasons for exclusion will be reported.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: COHORT
  • Perspectivas de Tempo: PROSPECTIVE

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
Prazo: Within 60 minutes after the end of extubation

The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation:

i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 < 80% for > 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation).

Within 60 minutes after the end of extubation

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Difficult airway and complications related to airway management if reintubation is required
Prazo: Within 60 minutes after the end of extubation

Difficult airway (i.e., experienced difficulty by an experienced airway manager with any or all of laryngoscopy or tracheal intubation, supraglottic airway use, face-mask ventilation, or front-of-neck airway) and complications related to airway management (e.g., esophageal intubation) if reintubation is required

Within 60 minutes after the end of extubation
Planned and unplanned non-invasive respiratory support
Prazo: Within 60 minutes after the end of extubation

Planned and unplanned non-invasive respiratory support or high flow nasal cannula

Within 60 minutes after the end of extubation
Emergency front of neck airway
Prazo: Within 60 minutes after the end of extubation

Emergency front of neck airway should airway management be required after extubation

Within 60 minutes after the end of extubation
Cardiac arrhythmia requiring chemical or electrical treatment
Prazo: Within 60 minutes after the end of extubation

Cardiac arrhythmia requiring chemical or electrical treatment

Within 60 minutes after the end of extubation
Severe Hypotension
Prazo: Within 60 minutes after the end of extubation

Severe hypotension (systolic arterial pressure < 65 mmHg recorded at any time or systolic arterial pressure < 90 mmHg for > 30 minutes or new need/increase of vasopressor and/or fluid load > 15 mL/kg)

Within 60 minutes after the end of extubation
Severe Hypertension
Prazo: Within 60 minutes after the end of extubation

Severe hypertension (systolic blood pressure ≥180 mmHg and/or diastolic blood pressure ≥120 mmHg),

Within 60 minutes after the end of extubation
Pulmonary aspiration
Prazo: Within 60 minutes after the end of extubation

Aspiration of gastric contents (gastric contents inhaled into the larynx and the respiratory tract)

Within 60 minutes after the end of extubation
Barotrauma
Prazo: Within 60 minutes after the end of extubation

Pneumothorax/pneumo-mediastinum

Within 60 minutes after the end of extubation
Dental injury
Prazo: Within 60 minutes after the end of extubation

Dental injury (notable change to the patient's dentition attributable to extubation or to reintubation, should this be required)

Within 60 minutes after the end of extubation
Airways injury
Prazo: Within 60 minutes after the end of extubation

Airways injury (e.g., vocal cord damage, arytenoid dislocation

Within 60 minutes after the end of extubation
Mortality
Prazo: Within 7 days after extubation

In-hospital mortality

Within 7 days after extubation
Re-intubation
Prazo: Within 48 hours after extubation

Re-intubation within 48 hours of extubation

Within 48 hours after extubation

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Matteo Parotto, MD, PhD, UHN

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

14 de abril de 2025

Conclusão Primária (Estimado)

1 de dezembro de 2027

Conclusão do estudo (Estimado)

1 de dezembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

28 de março de 2024

Enviado pela primeira vez que atendeu aos critérios de CQ

3 de junho de 2024

Primeira postagem (Real)

5 de junho de 2024

Atualizações de registro de estudo

Última Atualização Postada (Real)

22 de outubro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

19 de outubro de 2026

Última verificação

1 de agosto de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 24-5811
  • 4850 (Outro identificador: Clinical Trials Ontario - CTO)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever